- Titan Pharmaceuticals, Inc. (TTNP)
Titan Pharmaceuticals, Inc Nasdaq: TTNP Volume Day Low High 52-Week Low High Average Volume January 17, 2025 Saying Farewell and Sharing Thoughts on an Exciting Time for NIH Research Saying Farewell and Sharing Thoughts on an Exciting Time for NIH Research: Read Article
- Investor Relations :: Titan Pharmaceuticals, Inc. (TTNP)
In December 2021, Titan announced its intention to work with a financial advisor to explore strategic alternatives to enhance stockholder value, potentially including an acquisition, merger, reverse merger, other business combination, sales of assets, licensing or other transaction
- About Titan Pharmaceuticals
Titan Pharmaceuticals, Inc was incorporated as a Delaware corporation in 1992 Titan previously focused on developing therapeutics utilizing the proprietary long-term drug delivery platform, ProNeura®, for the treatment of select chronic diseases for which steady state delivery of a drug has the potential to provide an efficacy and or safety
- Company Information :: Titan Pharmaceuticals, Inc. (TTNP)
Titan is a development-stage biotechnology company developing proprietary therapeutics using its clinically proven ProNeura ® long-term, continuous drug delivery technology The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions where maintaining consistent, around-the-clock
- Profile :: Titan Pharmaceuticals, Inc. (TTNP)
Titan is a development-stage biotechnology company developing proprietary therapeutics using its clinically proven ProNeura ® long-term, continuous drug delivery technology The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions where maintaining consistent, around-the-clock
- News Events :: Titan Pharmaceuticals, Inc. (TTNP)
Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock
- Press Releases :: Titan Pharmaceuticals, Inc. (TTNP)
Titan Pharmaceuticals Announces $9 5 Million Private Placement of Convertible Preferred Stock September 18, 2023
- Titan Pharmaceuticals to Explore Strategic Alternatives
SOUTH SAN FRANCISCO, Calif , Dec 21, 2021 PRNewswire -- Titan Pharmaceuticals, Inc (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has commenced a process to explore and evaluate strategic alternatives to enhance shareholder value
|